OssDsign Marks 500 U.S. Cases with OssDsign Catalyst Orthobiologics ORTHOFLASH OssDsign Catalyst is a synthetic bone graft that stimulates the formation of healthy bone tissue in spinal fusion surgery. Jan 09, 2023
Ganymed Robotics Raises Additional Funding Investments The Numbers Funds will be used to complete development of Ganymed Robotics’ surgical robotic assistant for knee arthroplasty. Jan 06, 2023
OrthoPediatrics Establishes Direct Sales in Germany Company Updates Competitive Landscape OrthoPediatrics’ first direct international organization represents an expanding commitment to support pediatric orthopedics in international markets. Jan 06, 2023
First Surgical Cases with Life Spine ARx Spinal Fixation ORTHOFLASH Spine ARx is a highly adaptable system designed to support both degenerative and complex spinal pathologies with a wide variety of implants. Jan 06, 2023
Zimmer Biomet to Acquire Embody Sports Medicine Company Competitive Landscape Mergers & Acquisitions The acquisition includes the TAPESTRY biointegrative implant for tendon healing and TAPESTRY RC for rotator cuff repair. Jan 05, 2023
Orthofix and SeaSpine Complete Merger Competitive Landscape Mergers & Acquisitions The combined organization creates the eighth-largest spine company, with a portfolio spanning trauma, orthobiologics and bone growth therapies. Jan 05, 2023
Pristine Surgical Gains 510(k) for Summit Single-Use Arthroscope ORTHOFLASH Sports Medicine Summit is a first-of-its-kind 4K single-use surgical arthroscope designed to improve the efficiency and consistency of arthroscopic procedures. Jan 05, 2023
SI-BONE Granted New Indications for iFuse Bedrock Granite ORTHOFLASH Spine New cleared indications include use with a wide variety of commercially available pedicle screw system rods. Dec 27, 2022
Episurf Medical Gains FDA Clearance for Episealer Patellofemoral System Joint Replacement ORTHOFLASH The system provides two opposing implants, intended for patients with osteoarthritis limited to the distal patellofemoral joint in the knee. Dec 27, 2022
Lipogems Raises Funds for Knee Osteoarthritis Studies Investments The Numbers Lipogems utilizes autologous adipose tissue for therapeutic use in orthopedics and other specialties. Dec 27, 2022